In 2007, Morote et al. reported that PCa patients with micro-elevations in serum testosterone >32 ng/dL during LH-RH analogue treatment showed lower survival free of castration resistance than those without them [14]. This evidence concerns the gene GNRH1 and posterior cortical atrophy.